Pay in 4 interest-free payments of $6.45 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
Retatrutide targets GLP-1, GIP, and glucagon receptors for comprehensive metabolic action Phase 2 trials showed up to 24% body weight loss over 48 weeks in participants The medication is administered as a once-weekly injection, similar to existing treatments Eli Lilly is developing Retatrutide, with Phase 3 trials currently underway UK availability is not expected until at least 2026-2027 following regulatory approval Weight Loss Treatment Comparison Calculator Estimate potential weight loss based on current clinical trial data for different medications Based on average clinical trial results
Calories: 70
1 pre-filled multi-dose pen Full instructions Tamper-proof verification sticker 8 sterile needles 20mg CJC-1295 and Ipamorelin multi-dosage injection pen
HCG (human chorionic gonadotropin) While technically not a peptide (it's a glycoprotein hormone), HCG deserves mention as it's commonly used with peptides
as an addition to other medicines for the treatment of diabetes
&srotate=0)
